{"id":60920,"date":"2026-05-18T10:16:28","date_gmt":"2026-05-18T10:16:28","guid":{"rendered":"https:\/\/ibima.eu\/?p=60920"},"modified":"2026-05-18T11:27:58","modified_gmt":"2026-05-18T11:27:58","slug":"sam-eu","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/sam-eu\/","title":{"rendered":"SAM-eu"},"content":{"rendered":"

[et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.25.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbIntelligent Digital Twin for social prescribing in primary healthcare\u00bb _builder_version=\u00bb4.27.5″ _module_preset=\u00bbdefault\u00bb title_font=\u00bb||||||||\u00bb title_text_align=\u00bbcenter\u00bb title_text_color=\u00bb#0C71C3″ module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb2_3,1_3″ _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb30px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb2_3″ _builder_version=\u00bb4.25.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.5″ _module_preset=\u00bbdefault\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″]<\/p>\n

\n
\n
\n
\n
\n
\n

Financed by<\/span><\/strong>: Gobierno de Cantabria – Conserjer\u00eda de Econom\u00eda, Hacienda y Fondos Europeos.<\/span><\/span><\/p>\n

Program<\/strong>: Interreg SUDOE: Interreg VI-B Sudoe 2024. Velar por la igualdad de acceso a la asistencia sanitaria y reforzar la resiliencia de los sistemas sanitarios, en particular la atenci\u00f3n primaria, as\u00ed como fomentar la transici\u00f3n de la asistencia institucional a la asistencia en los \u00e1mbitos familiar y local.<\/span><\/p>\n

Project Reference:<\/b>S2l 4.5 I E027 1<\/span><\/span><\/p>\n

Role in the project:<\/strong> Partner<\/span><\/p>\n

Duration:<\/b> January 2025 to December 2028<\/span><\/p>\n

\u00a0<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n

\n
\n
\n
\n
\n
\n

Contacts: Ricardo Gomez Huelgas and Rosa Bernal<\/span><\/p>\n

Implementation Centre: Hospital Regional Universitario de M\u00e1laga<\/a> and <\/span>Distrito Sanitario M\u00e1laga-Guadalhorce<\/a><\/p>\n

Research group of IBIMA involved: <\/span><\/span>Diabetes, Obesity, and Other Vascular Risk Factors Systemic Autoimmune Diseases<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.25.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_post_title title=\u00bboff\u00bb meta=\u00bboff\u00bb image_height=\u00bb1000px\u00bb image_max_height=\u00bb176px\u00bb admin_label=\u00bbT\u00edtulo de publicaci\u00f3n\u00bb _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb title_font=\u00bbArial||||||||\u00bb title_text_align=\u00bbcenter\u00bb title_text_color=\u00bb#2ea3f2″ title_font_size=\u00bb35px\u00bb meta_text_align=\u00bbcenter\u00bb background_enable_color=\u00bboff\u00bb background_enable_image=\u00bboff\u00bb text_orientation=\u00bbcenter\u00bb width=\u00bb100%\u00bb max_width=\u00bb100%\u00bb module_alignment=\u00bbcenter\u00bb min_height=\u00bb100px\u00bb height=\u00bb100px\u00bb max_height=\u00bb100px\u00bb custom_margin=\u00bb21%||1%||false|false\u00bb title_font_size_last_edited=\u00bboff|desktop\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb||-48px||false|false\u00bb custom_padding=\u00bb50px||50px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.25.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbABSTRACT\u00bb _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb title_font=\u00bb||||||||\u00bb title_text_color=\u00bb#0C71C3″ custom_margin=\u00bb||5px|||\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.5″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb0px||19px||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

\n
\n
\n
\n
\n
\n

Social prescribing, an internationally recognized approach, involves recommending local assets in healthcare settings to improve population health and well-being. The World Health Organization (WHO) published a Guide for implementing social prescribing in primary care in 2022, yet there\u2019s a gap between health strategies (which highlight health assets and social determinants) and practice, with limited experience in Spain and Portugal, and none in France. The common Sudoe challenge is to implement social prescribing in primary care to enhance population health and well-being. The intelligent digital twin SAM (acronym for SAlud, Social, Activos y Mapa \u2013 Health, Social, Assets, and Map) is a web service that allows healthcare professionals to visualize social determinants and health assets near the patient, customizing healthy lifestyle routines and guidelines in real time, adapted to the local territory. This socio-health innovation project valorizes territorial heritage and local services that represent health assets, generating added-value opportunities, fostering community health, and signposting assets in the territory. The pilot is deployed across the 3 countries, anchored in 8 focal points of different problems across 8 NUTS II regions with 2 types of implementation: \u201clocal primary care\u201d in 6 focal points and \u201cspecial\u201d in 2 (one cross-border ES-PT and another for transfer to specialized oncological medicine in FR). SAM operates in rural and urban territories, seeking territorial balance and sociodemographic cohesion, targeting populations aged 6-18 and over 60. Implementation follows the 7 phases established by WHO, with SAM being innovative in health asset mapping (phase 4) and objective outcome evaluation (phase 7) \u2013 for the first time transnationally. Findings will be transferred to regional and national health policies, promoting cross-border cooperation, the valorization of local heritage for health, and equitable access to assets. A long-term strategic planning plan for SAM will guide its adaptation to opportunities, resilience to challenges, and transfer to other countries.<\/span><\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n

[\/et_pb_text][et_pb_text _builder_version=\u00bb4.27.5″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

\n
\n
\n
\n
\n
\n

Website of the Project<\/a><\/span><\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n

[\/et_pb_text][et_pb_heading title=\u00bbPartners\u00bb admin_label=\u00bbT\u00edtulo\u00bb _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb title_font=\u00bb||||||||\u00bb title_text_color=\u00bb#0C71C3″ custom_margin=\u00bb30px||11px||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.5″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n